A law firm <a href=" http://www.creativesummit.org/is-bactrim-ds-a-sulfa-drug#handle ">nome generico do remedio bactrim</a> "Today&#39;s recommendation is good news and a reflection of our commitment to giving an alternative treatment option for patients living with COPD--a disease that affects millions of Americans," GlaxoSmithKline President of Pharmaceuticals R&D Patrick Vallance said in a statement. "If approved, Anoro Ellipta will be the first, once-daily dual bronchodilator available in the US, marking another significant milestone for GSK&#39;s portfolio of medicines to treat respiratory disease. We will continue to work with the FDA as they complete their review."